Procedures in efficacy (active pediatric cohort) |
Census and clustering Months −10 to −4 |
Enrollment/baseline(E) Visit 1, day 1 |
Study visit 2(E) Day 31 +/−3 days |
Study visit 3(E) Day 61 +/− 3 days |
Study visit 4(E) Day 91 +/−3 days |
Study visit 5(E) Day 121 +/−3 days |
Study visit 6(E) Day 151 +/−3 days |
Study visit 7(E) Day 181 +/−3 days |
---|---|---|---|---|---|---|---|---|
Informed consent for census | X | |||||||
Demographic data collection | X | |||||||
Randomization | X | |||||||
Informed consent | X | |||||||
Anthropometry | X | X | X | |||||
Review infant vaccination card | X | X | X | |||||
Complete visit template | X | X | X | X | X | X | X | |
Malaria RDT | X | X | X | X | X | X | X | |
Malaria treatment a | X | X | X | X | X | X | X | |
Assessment of selected NTDs | X | X | X | X | X | X | X | |
COVID responseb | X | X | X | X | X | X | X | |
Malaria parasite immune response samples b | X | X | X | X | X | X | X | |
Plasmodium PCR for quality control and molFOIc | X | X | X | X | X | X | X | |
Passive incidence surveillance at health facilities (all ages) | X-------------------------------------------------------X |
aOnly if RDT is positive (see case definition)
bOnly in a randomly selected sub-sample
cOnly in a randomly selected 10% sub-sample